1. Home
  2. GL vs JAZZ Comparison

GL vs JAZZ Comparison

Compare GL & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$171.09

Market Cap

14.3B

Sector

Finance

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$246.11

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
JAZZ
Founded
1900
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
16.1B
IPO Year
1998
2007

Fundamental Metrics

Financial Performance
Metric
GL
JAZZ
Price
$171.09
$246.11
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$167.27
$217.57
AVG Volume (30 Days)
378.0K
853.9K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
0.71%
N/A
EPS Growth
17.84
N/A
EPS
7.04
7.17
Revenue
$5,994,318,000.00
$1,618,693,000.00
Revenue This Year
$9.64
$6.22
Revenue Next Year
$5.61
$7.68
P/E Ratio
$23.84
$33.66
Revenue Growth
3.74
N/A
52 Week Low
$127.85
$123.89
52 Week High
$191.55
$266.38

Technical Indicators

Market Signals
Indicator
GL
JAZZ
Relative Strength Index (RSI) 42.67 43.08
Support Level $168.99 $237.05
Resistance Level $177.00 $242.66
Average True Range (ATR) 3.17 7.29
MACD -0.39 -1.25
Stochastic Oscillator 34.15 17.98

Price Performance

Historical Comparison
GL
JAZZ

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: